Table 3.
Protein (Human) | Transition | Coefficient* | 95% CI* | p-value† | Tissue biomarker‡ | Biomarker in literature |
---|---|---|---|---|---|---|
LRP1 | TVLWPNGLSLDIPAGR_855.00_400.20 | −1.59 | (−2.39, −1.20) | 9.64E-05 | EPI | (38) |
BGH3 | LTLLAPLNSVFK_658.40_804.50 | 1.73 | (1.18, 2.53) | 4.37E-03 | (39) | |
COIA1 | AVGLAGTFR_446.26_721.40 | −1.56 | (−2.48, −1.16) | 3.90E-04 | (40) | |
TETN | LDTLAQEVALLK_657.39_330.20 | −1.79 | (−2.95, −1.21) | 6.71E-03 | (41) | |
TSP1 | GFLLLASLR_495.31_559.40 | 0.53 | (0.35, 0.93) | 1.13E-02 | (42) | |
ALDOA | ALQASALK_401.25_617.40 | −0.80 | (−1.21, −0.51) | 1.03E-02 | Secreted, EPI | (43) |
GRP78 | TWNDPSVQQDIK_715.85_260.20 | 1.41 | (0.91, 2.24) | 6.24E-03 | Secreted, EPI, ENDO | (44) |
ISLR | ALPGTPVASSQPR_640.85_841.50 | 1.40 | (0.85, 2.21) | 1.09E-02 | ||
FRIL | LGGPEAGLGEYLFER_804.40_913.40 | 0.39 | (0.24, 0.66) | 1.63E-02 | Secreted, EPI, ENDO | (45) |
LG3BP | VEIFYR_413.73_598.30 | −0.58 | (−0.97, −0.28) | 6.24E-02 | Secreted | (46) |
PRDX1 | QITVNDLPVGR_606.30_428.30 | −0.34 | (−0.64, −0.10) | 1.54E-01 | EPI | (47) |
FIBA | NSLFEYQK_514.76_714.30 | 0.31 | (0.16, 0.53) | 4.10E-02 | (48) | |
GSLG1 | IIIQESALDYR_660.86_338.20 | −0.70 | (−1.51, −0.19) | 1.60E-01 | EPI, ENDO | |
Constant | 36.16 | (19.72, 59.01) |
Based on 20,000 Monte Carlo cross validation permutations with a 20% hold-out rate: “Coefficient” is the corresponding median values from the permutations, “95% CI” is the corresponding 95% BCa confidence intervals (49).
Based on likelihood ratio test on the whole discovery dataset, comparing the models with or without the corresponding proteins.
See Supplementary Materials and Table S3 for details.